Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study
January 30, 2018 08:35 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from a pilot study conducted for...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201
December 05, 2013 12:49 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...